Search Results

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Pre-clinical assessment of SAR442257, a CD38/CD3xCD28 trispecific T cell engager in treatment of relapsed/refractory multiple myeloma by Grab, Anna Luise (Author) , Kim, Peter S. (Author) , John, Lukas (Author) , Bisht, Kamlesh (Author) , Wang, Hongfang (Author) , Baumann, Anja (Author) , Van de Velde, Helgi (Author) , Sarkar, Irene (Author) , Shome, Debarati (Author) , Reichert, Philipp (Author) , Manta, Calin-Petru (Author) , Gryzik, Stefanie (Author) , Reijmers, Rogier M. (Author) , Weinhold, Niels (Author) , Raab, Marc-Steffen (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: a case-based approach by Bärtsch, Marc-Andrea (Author) , Hundemer, Michael (Author) , Hillengaß, Jens (Author) , Goldschmidt, Hartmut (Author) , Raab, Marc-Steffen (Author) ,


    Get full text
    Article (Journal) Online Resource